TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Tsumura & Co ( (JP:4540) ) has issued an announcement.
Tsumura & Co. has completed the acquisition of a 51% stake in Shanghai Hongqiao Traditional Chinese Drug Pieces Co., Ltd., a company specializing in pharmaceutical production and traditional Chinese medicine services. This acquisition is expected to be reflected in Tsumura’s financial statements from the mid-term period of the fiscal year ending March 2026, potentially impacting the company’s earnings and dividend forecasts.
The most recent analyst rating on (JP:4540) stock is a Hold with a Yen3870.00 price target. To see the full list of analyst forecasts on Tsumura & Co stock, see the JP:4540 Stock Forecast page.
More about Tsumura & Co
Tsumura & Co. operates in the pharmaceutical industry, focusing on the production and wholesale of traditional Chinese medicine. The company is listed on the TSE Prime Market and is known for its traditional Chinese drug pieces and related services.
YTD Price Performance: -22.02%
Average Trading Volume: 390,846
Technical Sentiment Signal: Hold
Current Market Cap: Yen271.5B
Learn more about 4540 stock on TipRanks’ Stock Analysis page.